ViewRay Secures $20,000,000 Series C Financing Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=981d3c8f-c417-4c05-8e1d-904089c368c0&Preview=1 - Date
8/25/2010 - Company Name
ViewRay - Mailing Address
2 Thermo Fisher Way Oakwood Village, OH 44146 - Company Description
The patent pending Renaissance race System 1000 combines two proven technologies: magnetic resonance imaging (MRI) and gamma ray radiotherapy. Conversely, today’s competing image-guided radiotherapy systems are based on linear accelerators which require CT or X-Ray scanners to capture patient images—linacs cannot work with MRI because of technical incompatibilities between the two devices. Only the Renaissance System 1000, combining MRI and gamma ray radiotherapy, promises to provide real-time beam-on imaging and targeting of the tumor. - Website
http://www.viewray.com - Transaction Type
Venture Equity - Transaction Amount
$20,000,000 - Transaction Round
Series C - Proceeds Purposes
The funding is intended to move the ViewRay system, a unique image-guided radiation therapy system now in the late stages of development, through the process of commercialization and placement in major medical centers. - M&A Terms
- Venture Investor
Siemens Venture Capital - Venture Investor
Fidelity BioSciences - Venture Investor
Aisling Capital - Venture Investor
Kearny Venture Partners - Venture Investor
OrbiMed
